Microbiology: EHEC Downregulates Virulence in Response to Intestinal Fucose
Recent work has revealed that enterohaemorrhagic Escherichia coli encodes a two-component system, termed FusKR, which responds to fucose and represses expression of virulence genes. Furthermore, a representative member of the microbiota appears to cleave fucose from host glycans, indicating that the microbiota and EHEC may act in concert to suppress virulence gene expression.
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The environmental signals that trigger enterohaemorrhagic Escherichia coli (EHEC) to begin its virulent life cycle within the large intestine of its human host are beginning to be explored, yielding a better understanding of the early stages of this pathogen's strategy to colonize its host. Expression of the type III secretion system (T3SS) by EHEC is essential for virulence, enabling it to attach to the host by forming attaching and effacing lesions [1] . Attaching and effacing lesions are characterized by effacement (loss) of the intestinal microvilli and intimate attachment of the pathogen to the epithelial cell with pedestal-like structures underlying the bacterium [1] . The genes encoding the T3SS are located within a genetic island termed the locus of enterocyte effacement (LEE), which is under the control of a master regulator, Ler [1] . Following on from their earlier studies, the Sperandio group [2] now present a model for initial EHEC intestinal colonization, whereby fucose freed from the mucus layer by a member of the microbiota, Bacteroidetes thetaiotamicron, inhibits LEE expression, relieving the pathogen from the metabolic burden of expressing the T3SS and giving it a competitive growth advantage in the lumen of the gut. Once EHEC approaches the mucosal surface, adrenergic metabolites de-repress the LEE, initiating its adherence mechanisms ( Figure 1 ).
Prior work from this group showed that, upon exposure to external host adrenergic signals and the microbiota-generated autoinducer signal AI-3, two histidine sensor kinases undergo autophosphorylation and relay their phosphate to response regulators that enhance EHEC virulence [3, 4] . In addition to what was already known about the promotion of virulence phenotypes by AI-3 and adrenergic signals, the new study reports that two of these response regulators also repress expression of the FusKR two-component system, where FusK is the histidine sensor kinase and FusR the response regulator. This repression promotes virulence, since the presence of both fusK and fusR represses LEE gene expression [2] .
While these new findings suggest that adrenergic and AI-3 signals would repress fusKR through the activation of inhibitory response regulators, the study did identify a particular metabolite that represses the virulence of EHEC through the direct activation of FusKR. Expression of the fusKR response regulator is induced by mucus, a substrate that is rich in various sugar and lipid metabolites. Moreover, the FusK kinase specifically undergoes autophosphorylation in the presence of L-fucose. Most interesting, however, was the finding that B. thetaiotaomicron was able to repress ler expression when incubated with mucin, a derivative of mucus that contains bound fucose. These findings suggest that the fucosidases encoded by this abundant constituent of the human microbiota cleaves fucose from mucin to directly repress virulence expression [5] .
One of the implications of downregulating ler and therefore LEE expression by EHEC in the presence of fucose is the possibility that the pathogen enhances its survival by conserving its energy when in the highly competitive and nutrient-poor environment of the gastrointestinal tract. Intriguingly, the authors demonstrated that when EHEC is grown with fucose as the sole carbon source, deletion of fusK or fusR results in a faster initial doubling time. This makes sense because fusKR expression represses both a putative fucose transporter and fuc genes, which are critical for fucose utilization as a carbon source. However, when the authors did a competition assay with the fusK deletion mutant and wild-type EHEC in the same growth medium, wild-type EHEC were not outcompeted, indicating that, despite the initial doubling-time advantage of the fusK deletion strain, wild-type EHEC may also have a separate growth disadvantage that affects survival during competitive growth. When mucin was used as the sole carbon source, they found both that ler expression in wild-type EHEC was decreased when compared with growth in fucose and also that wild-type EHEC outcompeted the fusK mutant. These results suggest that repression of ler expression and therefore downregulation of the LEE may confer a competitive growth advantage to EHEC. Indeed, in an infant rabbit infection model, EHEC colonization in the mid-colon was impaired by the loss of fusK, but not additionally impaired by the loss of the fucose utilization regulator fucR. These results suggest that the increased expression of the fucose utilization system in the fusK deletion mutant is not the reason that wild-type EHEC outcompetes the fusK mutant, and the growth advantage seen in the infant rabbit infection model may be due to the ability of wild-type EHEC to repress ler and LEE-encoded virulence mechanisms.
While the new data suggest that expression of the LEE might be detrimental to in vivo and in vitro growth, it is also remarkable that EHEC has gained a system to downregulate utilization of a carbon source when exposed to it. Expression of genes essential for fucose utilization is increased upon deletion of fusKR, and expression of a putative fucose transporter is also increased upon deletion of fusK. These data indicate that the FusKR cognate pair, upon activation by fucose, represses not only LEE-controlled virulence phenotypes, but also E. coli systems that would transport and utilize fucose as a metabolic carbon source. Understandably, when fucose is presented to EHEC as the sole carbon source, EHEC is impaired in growth when compared with the fusK deletion mutant, through FusKR-mediated repression of fucose transport and utilization. The growth environment in the large intestine is rich in fucose [6] , which is presumably provided by the cleavage of host mucin by the Bacteroidetes phylum or other members of the resident microbiota. While it may seem counterintuitive for a pathogen to abstain from an abundant carbon source it may encounter within the host, they showed that growth upon an alternative carbon source, galactose, is not impaired when fusK and fusR are both deleted. This is intriguing, as galactose is not utilized by other commensal E. coli commonly found within the intestine, whereas fucose is [7] , indicating that EHEC is actively repressing ancestral fucose usage pathways in an environment where the use of fucose may already be Figure 1 . Model for FusKR-mediated modulation of EHEC virulence in response to microbiotagenerated fucose, auto-inducer-3, and host-generated adrenergic signals. This new work has demonstrated that FusKR is activated by both fucose and mucin in the presence of Bacteroidetes. Additionally, expression of EHEC fucose transport genes, EHEC fucose utilization genes, and the LEE pathogenicity island of EHEC were all repressed in the absence of the fusK and fusR genes, leading to speculation that FusKR contributes to EHEC fitness in the lumen of the gastrointestinal tract. Conversely, response regulators that are activated by host-generated adrenergic signals and the microbiota-generated autoinducer 3 signal repress expression of fusKR and increase expression of EHEC virulence factors. Together, this study and prior work by the same group demonstrate that EHEC can respond to multiple metabolites in the host to modulate virulence and perhaps also promote competitive growth in the host.
under fierce competition by commensal strains of E. coli.
These findings suggest that EHEC may have evolved mechanisms to avoid expending energy to transport and utilize a nutrient that is actively being used by other microbes, possibly giving EHEC a competitive advantage over the microbiota. The fusKR genes, while present in the EHEC O157:H7 serotype, are notably absent in all other published genomes of E. coli. It remains to be seen whether repression of fucose utilization by the FusKR response regulator confers a growth advantage upon EHEC because it can utilize alternative unique carbon sources while commensal strains of E. coli cannot, but it would be telling if transfer of the cognate FusKR pair to commensal strains of E. coli conferred a growth disadvantage to them in the host. This would raise the mirror question: if EHEC uses the FusKR two-component system to abstain from a carbon source that other microbiota members use while in the gastrointestinal tract, has EHEC gained specific mechanisms to utilize unique carbon sources that do not exist in commensal microbiota members?
The repression of virulence gene expression by a member of the microbiota when EHEC is in the presence of mucus raises many unanswered questions. Would an individual with an unbalanced microbiota scant in Bacteroidetes be more susceptible or less susceptible to EHEC disease? Do the varying concentrations of mucus and fucose present throughout the entire gastrointestinal tract have a direct influence upon the colonization site of EHEC within the large intestine? Will high fucose concentrations encountered by shedding EHEC cause the pathogen to conserve its energy by repressing virulence gene expression and result in a pathogen that is more or less fit for transmission? Future research will no doubt shed light on these issues.
